Components of gram-negative bacterial cell walls, called lipopolysaccharides (LPS) , function as endotoxins
GLP-1 Drug Market Size, Share, Growth, and Industry Analysis, By Types (Short-acting GLP-1 Drug,Long-acting GLP-1 Drug), By Applications (Obesity,Type 2 Diabetes (T2DM),Cardiovascular and Cerebrovascular Diseases (CVD),Non-alcoholic Steatohepatitis (NASH),Alzheimer's Disease (AD)) , and Regional Insights and Forecast to 2035 Last Updated: 23-March-2026 Base Year: 2025 Historical Data: 2021-2024 Region: Global Report ID: GGI124388 SKU ID: 30248947 Pages: 113 GLP-1 Drug Market Size The Global GLP-1 Drug Market is expanding rapidly, with the market size valued at USD 37.57 billion in 2025 and projected to reach USD 47.6 billion in 2026, further advancing to USD 60.31 billion in 2027 and USD 400.5 billion by 2035, exhibiting a CAGR of 26.7% during the forecast period
It is produced naturally in the body out of lysine and methionine, but in pets with heart issues or too much fat in their bodies, more carnitine may be supplemented
We measure how youre aging then design smarter, data-backed plans that grow with you
(2013) Available online at: (accessed March 25, 2019)
Yang YL
